Lymphatic biodistribution of polylactide nanoparticles

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Cancer Research

Background:

• Tumor metastasis utilizes both cardiovascular and lymphatic systems.
• Existing nanoparticle biodistribution research primarily focuses on the cardiovascular circulation.
• Understanding lymphatic nanoparticle transport is crucial for targeted cancer therapies.

Purpose of the Study:

• To formulate Cy5-labeled polylactide (Cy5-PLA) nanoparticles with controlled characteristics.
• To evaluate the lymphatic biodistribution of these Cy5-PLA nanoparticles.
• To explore the potential of lymphatic drug delivery for metastatic cancer treatment.

Main Methods:

• Formulation of Cy5-PLA nanoparticles via ring-opening polymerization and nanoprecipitation.
• Controlled nanoparticle size and surface feature engineering.
• In vivo lymphatic biodistribution assessment using whole-body and ex vivo fluorescence imaging in nude mice.

Main Results:

• Successful formulation of Cy5-PLA nanoparticles with tunable properties.
• Demonstrated lymphatic biodistribution of the nanoparticles in a mouse model.
• Visualized nanoparticle distribution within the lymphatic system using fluorescence imaging.

Conclusions:

• Cy5-PLA nanoparticles can be effectively formulated and tracked within the lymphatic system.
• This approach offers a method for evaluating lymphatic biodistribution.
• Optical imaging and lymphatic drug delivery hold promise for treating metastatic cancers.